Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Overnight levels of luteinizing hormone, follicle-stimulating hormone and growth hormone before and during gonadotropin-releasing hormone analogue treatment in short boys born small for gestational age.
van der Kaay DC, de Jong FH, Rose SR, Odink RJ, Bakker-van Waarde WM, Sulkers EJ, Hokken-Koelega AC. van der Kaay DC, et al. Among authors: odink rj. Horm Res. 2009;71(5):260-7. doi: 10.1159/000208799. Epub 2009 Apr 1. Horm Res. 2009. PMID: 19339790 Free article. Clinical Trial.
Efficacy and safety of long-term continuous growth hormone treatment in children with Prader-Willi syndrome.
de Lind van Wijngaarden RF, Siemensma EP, Festen DA, Otten BJ, van Mil EG, Rotteveel J, Odink RJ, Bindels-de Heus GC, van Leeuwen M, Haring DA, Bocca G, Houdijk EC, Hoorweg-Nijman JJ, Vreuls RC, Jira PE, van Trotsenburg AS, Bakker B, Schroor EJ, Pilon JW, Wit JM, Drop SL, Hokken-Koelega AC. de Lind van Wijngaarden RF, et al. Among authors: odink rj. J Clin Endocrinol Metab. 2009 Nov;94(11):4205-15. doi: 10.1210/jc.2009-0454. Epub 2009 Oct 16. J Clin Endocrinol Metab. 2009. PMID: 19837938
Beneficial effects of growth hormone treatment on cognition in children with Prader-Willi syndrome: a randomized controlled trial and longitudinal study.
Siemensma EP, Tummers-de Lind van Wijngaarden RF, Festen DA, Troeman ZC, van Alfen-van der Velden AA, Otten BJ, Rotteveel J, Odink RJ, Bindels-de Heus GC, van Leeuwen M, Haring DA, Oostdijk W, Bocca G, Mieke Houdijk EC, van Trotsenburg AS, Hoorweg-Nijman JJ, van Wieringen H, Vreuls RC, Jira PE, Schroor EJ, van Pinxteren-Nagler E, Willem Pilon J, Lunshof LB, Hokken-Koelega AC. Siemensma EP, et al. Among authors: odink rj. J Clin Endocrinol Metab. 2012 Jul;97(7):2307-14. doi: 10.1210/jc.2012-1182. Epub 2012 Apr 16. J Clin Endocrinol Metab. 2012. PMID: 22508707 Free article. Clinical Trial.
High serum levels of growth hormone (GH) and insulin-like growth factor-I (IGF-I) during high-dose GH treatment in short children born small for gestational age.
van Dijk M, Mulder P, Houdijk M, Mulder J, Noordam K, Odink RJ, Rongen-Westerlaken C, Voorhoeve P, Waelkens J, Stokvis-Brantsma J, Hokken-Koelega A. van Dijk M, et al. Among authors: odink rj. J Clin Endocrinol Metab. 2006 Apr;91(4):1390-6. doi: 10.1210/jc.2005-1663. Epub 2006 Feb 7. J Clin Endocrinol Metab. 2006. PMID: 16464954 Free article.
Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial.
Willemsen RH, Arends NJ, Bakker-van Waarde WM, Jansen M, van Mil EG, Mulder J, Odink RJ, Reeser M, Rongen-Westerlaken C, Stokvis-Brantsma WH, Waelkens JJ, Hokken-Koelega AC. Willemsen RH, et al. Among authors: odink rj. Clin Endocrinol (Oxf). 2007 Oct;67(4):485-92. doi: 10.1111/j.1365-2265.2007.02913.x. Epub 2007 Jun 11. Clin Endocrinol (Oxf). 2007. PMID: 17561977 Clinical Trial.
Bone mineral density and effects of growth hormone treatment in prepubertal children with Prader-Willi syndrome: a randomized controlled trial.
de Lind van Wijngaarden RF, Festen DA, Otten BJ, van Mil EG, Rotteveel J, Odink RJ, van Leeuwen M, Haring DA, Bocca G, Mieke Houdijk EC, Hokken-Koelega AC. de Lind van Wijngaarden RF, et al. Among authors: odink rj. J Clin Endocrinol Metab. 2009 Oct;94(10):3763-71. doi: 10.1210/jc.2009-0270. Epub 2009 Jul 21. J Clin Endocrinol Metab. 2009. PMID: 19622627 Clinical Trial.
Metabolic Health in Short Children Born Small for Gestational Age Treated With Growth Hormone and Gonadotropin-Releasing Hormone Analog: Results of a Randomized, Dose-Response Trial.
van der Steen M, Lem AJ, van der Kaay DC, Bakker-van Waarde WM, van der Hulst FJ, Neijens FS, Noordam C, Odink RJ, Oostdijk W, Schroor EJ, Westerlaken C, Hokken-Koelega AC. van der Steen M, et al. Among authors: odink rj. J Clin Endocrinol Metab. 2015 Oct;100(10):3725-34. doi: 10.1210/jc.2015-2619. Epub 2015 Aug 10. J Clin Endocrinol Metab. 2015. PMID: 26259134 Clinical Trial.
Efficacy and safety of oxandrolone in growth hormone-treated girls with turner syndrome.
Menke LA, Sas TC, de Muinck Keizer-Schrama SM, Zandwijken GR, de Ridder MA, Odink RJ, Jansen M, Delemarre-van de Waal HA, Stokvis-Brantsma WH, Waelkens JJ, Westerlaken C, Reeser HM, van Trotsenburg AS, Gevers EF, van Buuren S, Dejonckere PH, Hokken-Koelega AC, Otten BJ, Wit JM. Menke LA, et al. Among authors: odink rj. J Clin Endocrinol Metab. 2010 Mar;95(3):1151-60. doi: 10.1210/jc.2009-1821. Epub 2010 Jan 8. J Clin Endocrinol Metab. 2010. PMID: 20061421 Clinical Trial.
60 results